Join the Imkeldi group to help and get support from people like you.
Imkeldi News
Monthly News Roundup - November 2024
Bimzelx Indications Expanded to Include Hidradenitis Suppurativa, a Debilitating Skin Condition UCB’s Bimzelx (bimekizumab-bkzx) has been granted a new use for the treatment of adults with moderate t...
FDA Approves Imkeldi (imatinib) Oral Solution for the Treatment of Certain Forms of Leukemia and Other Cancers
CAMBRIDGE, Mass.-- November 25, 2024 --Shorla Oncology (‘Shorla’), a U.S.-Ireland specialty pharmaceutical company, announced today that the FDA has approved Imkeldi (imatinib) oral solution, the fir...
Further information
Related condition support groups
Chronic Myelogenous Leukemia (CML), Acute Lymphoblastic Leukemia